CD9 and breast cancer: The potential role of CD9 in metastasis was indicated in a different study, describing increased expression of CD9 in breast cancer bone metastasis compared to primary tumors, where CD9 antibody treatment in vivo moderately inhibited the progression of bone lesions (73).